Log In
Print
BCIQ
Print
Print this Print this
 

GDF-8 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Rigel Pharmaceuticals Inc.
DescriptionGDF-8 inhibitor
Molecular Target Myostatin (GDF8) (MSTN)
Mechanism of ActionMyostatin (GDF-8) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMuscular atrophy
Indication DetailsTreat muscular atrophy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today